Tenet Healthcare Files 8-K on Financials
Ticker: THC · Form: 8-K · Filed: Feb 12, 2025 · CIK: 70318
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: THC
TL;DR
Tenet Healthcare (THC) dropped an 8-K on Feb 12th covering financials. Check it out.
AI Summary
On February 12, 2025, Tenet Healthcare Corp. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 14201 Dallas Parkway, Dallas, TX 75254. Tenet Healthcare Corp. was formerly known as National Medical Enterprises Inc. /NV/.
Why It Matters
This filing provides investors with crucial updates on Tenet Healthcare's operational and financial performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant risks.
Key Players & Entities
- TENET HEALTHCARE CORP (company) — Registrant
- National Medical Enterprises Inc. /NV/ (company) — Former company name
- February 12, 2025 (date) — Date of report
- 14201 Dallas Parkway, Dallas, TX 75254 (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Tenet Healthcare Corp.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on February 12, 2025.
What is Tenet Healthcare Corp.'s state of incorporation?
Tenet Healthcare Corp. is incorporated in Nevada.
What was Tenet Healthcare Corp.'s former company name?
Tenet Healthcare Corp.'s former company name was National Medical Enterprises Inc. /NV/.
Where are Tenet Healthcare Corp.'s principal executive offices located?
Tenet Healthcare Corp.'s principal executive offices are located at 14201 Dallas Parkway, Dallas, TX 75254.
Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-02-12 06:47:26
Key Financial Figures
- $0.05 — nge on which registered Common stock, $0.05 par value THC NYSE 6.875% Senior Notes
Filing Documents
- thc-20250212.htm (8-K) — 29KB
- thc-20241231ex991earningsr.htm (EX-99.1) — 636KB
- tenethealthrgba.jpg (GRAPHIC) — 109KB
- 0000070318-25-000005.txt ( ) — 1025KB
- thc-20250212.xsd (EX-101.SCH) — 2KB
- thc-20250212_def.xml (EX-101.DEF) — 17KB
- thc-20250212_lab.xml (EX-101.LAB) — 29KB
- thc-20250212_pre.xml (EX-101.PRE) — 18KB
- thc-20250212_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. The information contained herein is being furnished pursuant to Item 2.02 of Form 8-K, "Results of Operations and Financial Condition." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On February 12, 2025 , Tenet Healthcare Corporation (the "Company") issued a press release reporting the financial results of the Company for the quarter ended December 31, 2024. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued on February 12, 2025 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: February 12, 2025 By: /s/ R. SCOTT RAMSEY R. Scott Ramsey Senior Vice President, Controller